Arcadia Biosciences(RKDA) - 2024 Q1 - Quarterly Results
Exhibit 99.2 Arcadia Biosciences, Inc. Consolidated Balance Sheets (Unaudited) (In thousands, except share data and per share data) | | | | Three Months Ended March 31, | | | --- | --- | --- | --- | --- | | | | 2024 | | 2023 | | Revenues: | | | | | | Product | $ | 1,255 | $ | 1,232 | | Total revenues | | 1,255 | | 1,232 | | Operating expenses (income): | | | | | | Cost of revenues | | 820 | | 688 | | Research and development | | 272 | | 359 | | Loss (Gain) on sale of property and equipment | | 2 | | (19 ) | ...